| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 01/19/1993 | US5180811 Proteins having a tnf action comprising tnf-fibromectin fusion protein |
| 01/19/1993 | US5180714 Adenosine compounds for the treatment of diseases caused by parasitic protozoa |
| 01/19/1993 | CA2074062A1 Dithiane |
| 01/13/1993 | EP0522937A1 Taxane derivatives containing compositions |
| 01/13/1993 | EP0522936A1 Taxane derivatives containing compositions |
| 01/13/1993 | EP0522173A1 4-desoxy-4-epipodophyllotoxin derivative or pharmaceutically acceptable salt thereof |
| 01/13/1993 | EP0522152A1 Lhrh antagonists |
| 01/13/1993 | EP0522081A1 Inhibition of disease associated with immunodeficiency virus infection |
| 01/13/1993 | EP0522078A1 Gp75 as a tumor vaccine for melanoma |
| 01/13/1993 | EP0522070A1 MOLECULAR CLONING OF THE GENES RESPONSIBLE FOR COLLAGENASE PRODUCTION FROM $i(CLOSTRIDIUM HISTOLYTICUM) |
| 01/12/1993 | US5179120 Porphycene compounds for photodynamic therapy |
| 01/12/1993 | US5179078 Method of suppressing tumor formation in vivo |
| 01/12/1993 | CA1312704C Grf analogs vii |
| 01/12/1993 | CA1312599C 2',3'dideoxy-2',2'difluoronucleosides |
| 01/12/1993 | CA1312598C 4-demethoxy anthracycline derivatives |
| 01/09/1993 | CA2046484A1 Peptides |
| 01/07/1993 | WO1993000436A1 Papillomavirus l2 protein |
| 01/07/1993 | WO1993000431A1 Ctl4a receptor, fusion proteins containing it and uses thereof |
| 01/07/1993 | WO1993000425A1 A novel receptor-type tyrosine kinase and use thereof |
| 01/07/1993 | WO1993000362A1 New peptides (didemnins), their preparation and their use |
| 01/07/1993 | WO1993000332A1 Substituted azetidinones as anti-inflammatory and antidegenerative agents |
| 01/07/1993 | WO1993000087A1 Porphycene compounds for photodynamic therapy |
| 01/07/1993 | WO1993000084A1 Methods and compositions for treating malaria and other diseases |
| 01/07/1993 | WO1993000070A1 Controlled release systems and low dose androgens |
| 01/07/1993 | WO1993000052A1 Treatment of diseases by site-specific instillation of cells or site-specific transformation of cells and kits therefor |
| 01/07/1993 | WO1993000051A1 Treatment of diseases by site-specific instillation of cells or site-specific transformation of cells and kits therefor |
| 01/07/1993 | EP0521692A2 Inhibition of tumor cell metastasis potential and invasiveness by chemically-defined oligosaccharides, their derivatives, mimetics and antibodies directed to them |
| 01/07/1993 | EP0521458A1 Mono and bis alkylamino-anthracyclines |
| 01/07/1993 | EP0521381A1 Use of 3-pyridazinone compounds to reduce blood platelet count |
| 01/07/1993 | EP0521353A1 Antineoplastic medicament containing octadecyl-[2-(N-methylpiperidino)-ethyl] phosphate and synthesis thereof |
| 01/07/1993 | EP0506830A4 Uncharged morpholino-based polymers having phosphorous-containing chiral intersubunit linkages |
| 01/07/1993 | EP0390849B1 Methyl cellulose pharmaceutical composition |
| 01/07/1993 | CA2580812A1 Ctla4 receptor, fusion proteins containing it and uses thereof |
| 01/07/1993 | CA2112393A1 Controlled release systems and low dose androgens |
| 01/07/1993 | CA2112376A1 Treatment of diseases by site-specific instillation of cells or site-specific transformation of cells and kits therefor |
| 01/07/1993 | CA2112375A1 Treatment of diseases by site-specific instillation of cells or site-specific transformation of cells and kits therefor |
| 01/07/1993 | CA2111323A1 Porphycene compounds for photodynamic therapy |
| 01/06/1993 | CN1067580A Megestrol acetate formulation |
| 01/06/1993 | CA2073117A1 Blood platelet-decreasing therapeutic drug |
| 01/05/1993 | US5177198 Process for preparing oligoribonucleoside and oligodeoxyribonucleoside boranophosphates |
| 01/05/1993 | US5177071 Tranquilizers |
| 01/05/1993 | US5177017 Molecular cloning of the genes responsible for collagenase production from Clostridium histolyticum |
| 01/05/1993 | CA1312336C Aromatic polycyclic derivatives, their preparation process and their use in human and veterinary medicine as well as in cosmetics |
| 01/05/1993 | CA1312329C Epipodophyllotoxin glucoside lactam derivatives |
| 01/02/1993 | CA2072834A1 Ketone derivatives |
| 01/02/1993 | CA2072824A1 Cluster conjugates of drugs with antibodies |
| 12/30/1992 | EP0520834A2 Pharmaceutical composition for treating an immune system disorder comprising PP14 or antibodies against PP14 |
| 12/30/1992 | EP0520823A2 Non-substrate peptide inhibitors of farnesyl protein transferase |
| 12/30/1992 | EP0520722A1 Therapeutic preparations containing quinazoline derivatives |
| 12/30/1992 | EP0520573A1 Cyclic imide derivatives |
| 12/30/1992 | EP0520427A1 Cyclopropenone derivatives |
| 12/30/1992 | EP0520029A1 Methods and compositions for the treatment of malignancies in which a protein kinase is associated. |
| 12/30/1992 | EP0211863B1 Vitamin d derivatives and methods for preparing same |
| 12/29/1992 | US5175315 Reacting with alcohol in presence of altivating agent |
| 12/29/1992 | US5175182 Antitumor agent; distamycin A derivatives |
| 12/29/1992 | US5175005 Administering ribonuclease inhibitors |
| 12/29/1992 | CA2072048A1 Non-substrate inhibitors of farnesyl protein transferase |
| 12/29/1992 | CA2072033A1 Non-substrate inhibitors of farnesyl protein transferase |
| 12/29/1992 | CA2071087A1 Therapeutic preparations |
| 12/29/1992 | CA2064544A1 Immune cell proliferation inhibitors |
| 12/29/1992 | CA1312074C Epipodophyllotoxin glucoside 4'-acyl derivatives |
| 12/29/1992 | CA1312025C Monoclonal antibodies and antigen for human non-small cell lung carcinomaand certain other human carcinomas |
| 12/28/1992 | CA2072551A1 Cyclic imide derivatives |
| 12/26/1992 | CA2072215A1 New substituted azetidinones as anti-inflammatory and antidegenerative agents |
| 12/24/1992 | DE4120327A1 Neue peptide, ihre herstellung und verwendung New peptides, their preparation and use |
| 12/23/1992 | WO1992022664A1 Chemotactic factor |
| 12/23/1992 | WO1992022653A1 Method for making humanized antibodies |
| 12/23/1992 | WO1992022583A2 Tri- and tetra-valent monospecific antigen-binding proteins |
| 12/23/1992 | WO1992022537A1 New selective aromatase inhibiting 4(5)-imidazoles |
| 12/23/1992 | WO1992022322A1 Lhrh analogs |
| 12/23/1992 | WO1992016612A3 Method of inhibiting padgem-mediated interactions using an inhibitor comprising a 2,6 sialic acid component |
| 12/23/1992 | EP0519678A2 1,4-Benzodiazepines with 6-membered heterocyclic rings |
| 12/23/1992 | EP0519351A2 Megestrol acetate formulation |
| 12/23/1992 | EP0519099A1 Direct compression cyclophosphamide tablet |
| 12/23/1992 | EP0518960A1 Derivatives of n-phenyl glycinamide, their preparation and medicaments containing them. |
| 12/23/1992 | EP0518933A1 Leukaemia inhibitory factor |
| 12/23/1992 | EP0256137B1 Bis-dioxopiperazine derivatives |
| 12/23/1992 | CN1067244A Pyrrolidones |
| 12/23/1992 | CA2481259A1 Method for making humanized antibodies |
| 12/23/1992 | CA2111469A1 New selective aromatase inhibiting 4(5)-imidazoles |
| 12/22/1992 | US5173486 Dibenz[b,f][1,4]oxazepin-11(10H)-ones for multidrug resistance reversing agents |
| 12/22/1992 | US5173420 Monoclonal antibody recognizing un-natural ganglioside gd3 |
| 12/22/1992 | CA1311704C Substantially purified tumor growth inhibitory factor (tif) |
| 12/20/1992 | WO1992022310A1 Asialoglycoprotein-conjugated medicinal agent |
| 12/20/1992 | CA2089881A1 Asialoglycoprotein-conjugated medicinal agent |
| 12/19/1992 | CA2071456A1 Method of treating adult t-cell leukemia/lymphoma |
| 12/19/1992 | CA2071141A1 Megestrol acetate formulation |
| 12/18/1992 | CA2071180A1 1,4-benzodiazepines with 6-membered heterocyclic rings |
| 12/16/1992 | EP0518753A1 Derivatives of 1,5-diyne-3-cycloalcene, their process of preparation and pharmaceutical compositions containing them |
| 12/16/1992 | EP0518731A1 Heterocyclic derivatives of substituted 2-acylamino 5-thiazole, their preparation and pharmaceutical compositions containing them |
| 12/16/1992 | EP0518706A2 An inbihiting agent against proliferation of malignant tumour cells of animals (including human beings)and methods for its manufacture |
| 12/16/1992 | EP0518645A1 Platinum (II) complex and antitumor agent |
| 12/16/1992 | EP0518414A1 Thioxanthenone antitumor agents |
| 12/16/1992 | EP0518413A1 Thioxanthenone antitumor agents |
| 12/16/1992 | EP0517829A1 Improved chimeric toxins |
| 12/16/1992 | EP0517815A1 AN IgG-1 HUMAN MONOCLONAL ANTIBODY REACTIVE WITH AN HIV-1 GLYCOPROTEIN AND METHOD OF USE |
| 12/16/1992 | EP0517789A1 Inhibitor of proliferation of endothelial cells. |
| 12/16/1992 | EP0517754A1 Antibody constructs with enhanced binding affinity |
| 12/16/1992 | EP0336958B1 Product containing as active principles: a) a peptide having an activity of the type of that of human gamma interferon, b) hydroxyurea |
| 12/16/1992 | CN1067057A Process for preparing unsaturated 17 -substituted 3-carboxysteroids |